Prognostic Significance of Transcript-Type <i>BCR - ABL1</i> in Chronic Myeloid Leukemia.

Mediterr J Hematol Infect Dis · 2020 · PMC7485470 · PMID 32952973

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

an unfavorable trendno p-value reported

22 In IFNα, although e13a2 transcript was associated with an unfavorable trend in outcomes and treatment responses, no data were sufficient to define the type of transcript as an independent prognostic factor.

also in 104 other papers

showed a trendno p-value reported

Similarly, for MMR and MR4.5, the e13a2 group who received imatinib 400 mg daily showed a trend of a lower response rate compared with the groups of patients treated with other TKI approaches.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.